Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.
about
CD36: implications in cardiovascular diseaseGene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breedVasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanomaChronic delivery of a thrombospondin-1 mimetic decreases skeletal muscle capillarity in miceAnti-angiogenic peptides for cancer therapeuticsABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.Original insights on thrombospondin-1-related antireceptor strategies in cancer.Comparative oncology today.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationPeripheral blood biomarkers of solid tumor angiogenesis in dogs: a polychromatic flow cytometry pilot study.Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein sheddingThrombospondin-based antiangiogenic therapy.Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.Antiangiogenic and anticancer molecules in cartilage.Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors.Murine and canine models of appendicular osteosarcoma.VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.Aiding and ABT'ing Treatment for Glioblastoma.Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.Thrombospondins function as regulators of angiogenesis.ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma modelProspective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer
P2860
Q24678338-C6143160-7878-46E8-BF64-5205CA0A3A8AQ30863814-E991A617-D218-4B7E-9805-583AE8FFF6B4Q33112684-C16DBB79-D3CA-4255-94B8-54CE7525CF7CQ33742809-0D7795CC-85AF-4EC2-9181-B2F4E780EBA4Q33790743-6CC865CD-CCF0-47BA-B6A9-BBE80B8CFCA8Q34584625-EF462202-D300-493F-8AB4-7D3F8F293BCCQ35043016-CBF61428-714F-4E88-BB24-3BE66DCD9384Q36060215-8C5F00D9-F2B3-44CB-8355-D65E6B43D5E5Q36221374-05604D04-0C55-444A-B636-4939DC392F0CQ36327751-0E4B2496-D8F9-4084-9713-528AB2091972Q36578825-712F3B7E-9C7B-4D78-BB26-CB00DB0EE749Q36605109-27BF524A-FC82-41BF-A481-FE42BEBD3E3AQ36804675-EA0917C9-1D07-4ABB-A573-7C29E44BE6C1Q36845405-98466AD6-7FE6-45D4-BB06-D38164F0B016Q37294120-E47C9DC1-1926-4EB6-AF9A-8A26555C0476Q37963916-A8A7670C-FFA6-4341-9176-A76E5B7022E5Q38007565-53AB4AEF-7003-47A8-912E-4C2A2ADA8F43Q38220804-156ED3C6-B186-4E64-B729-0419128225F2Q39725116-71E7675B-58A8-4B43-A161-E0DB2BD81D90Q40126394-CD4A758B-8576-452E-8414-4E4D01FBABBAQ42039078-214F5753-7734-436F-9251-3EC14D34FE95Q42324168-8646DCD5-1685-4216-A6DA-ABAF7DBC3558Q42379504-4AEBA60E-AF0C-425D-8228-451E65235D06Q42643939-CFDA1521-FE62-4745-A712-152D3124A5A2Q43104986-8F36DA5C-9925-4938-8547-00900F39C41AQ57530074-347ACEC3-824C-4F9E-95BC-FF3DED8F9A3EQ57541220-50591F63-8E15-45A6-8011-27E6F4A849C2
P2860
Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Preclinical evaluation of anti ...... h naturally occurring cancers.
@en
Preclinical evaluation of anti ...... h naturally occurring cancers.
@nl
type
label
Preclinical evaluation of anti ...... h naturally occurring cancers.
@en
Preclinical evaluation of anti ...... h naturally occurring cancers.
@nl
prefLabel
Preclinical evaluation of anti ...... h naturally occurring cancers.
@en
Preclinical evaluation of anti ...... h naturally occurring cancers.
@nl
P2093
P1476
Preclinical evaluation of anti ...... h naturally occurring cancers.
@en
P2093
Anthony Rusk
Chand Khanna
Evelyn McKeegan
Fortuna Haviv
Jack Henkin
Sandra Majest
P304
P356
10.1158/1078-0432.CCR-06-0109
P407
P577
2006-12-01T00:00:00Z